Aap Implantate : submits CE marking application for its innovative antibacterial silver coating technology more

aapsubmits CE marking application for its innovative antibacterial silver coating technology

aapImplantate AG (XETRA: AAQ.DE) announces that the design dossier for the performance of a CE conformity assessment procedure for the antibacterial silver coating technology developed by the company was recently submitted to a notified body leading in the field of medical products. The conformity assessment procedure will initially be undertaken for a silver-coated LOQTEQ® plate. In case of a successful conformity assessment, the company plans to extend the approval to further trauma products.

aapImplantate AG's silver coating technology addresses infection prevention, which is one of the critical problems in surgery that haven't yet been resolved adequately. During a procedure medical implants can become colonized by bacteria from the surrounding area forming a biofilm thereafter which can cause serious infections later. Both antibiotics and the human immune system have only a very limited effect against biofilms. It is therefore desirable to combat the biofilm formation at an early stage. This is where aapImplantate AG's silver coating technology becomes effective by protecting the implants' surface against bacterial colonisation. As there are no considerable resistances against silver the coating also protects against the colonisation by the particular problematic multiresistant germs.

The unique selling propositions of the silver coating technology developed by aapImplantate AG have been demonstrated in diverse trials and consist of the high coating stability as well as the good biocompatibility and effectiveness. It is furthermore a cost-efficient coating technology due to the relatively short coating time and the comparatively low capital investment for the required coating machines.

Overall aapImplantate AG's silver coating technology has a wide range of applications as a platform technology and can in a next step be used inter alia in other areas such as cardiology and dentistry or for a variety of medical instruments.

By submitting the design dossier for the performance of a CE conformity assessment procedure for the silver coating technology aapImplantate AG makes important progress regarding its strategic objective to accelerate value-based innovations.

This release contains forward-looking statements based on current experience, estimates and projections of the management board and currently available information. They are not guarantees of future performance. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. Many factors could cause the actual results, performance or achievements of aapto be materially different from those that may be expressed or implied by such statements. These factors include those discussed in aap's public reports. Forward-looking statements therefore speak only as of the date they are made. aapdoes not assume any obligation to update the forward-looking statements contained in this release or to conform them to future events or developments

aap Implantate AG issued this content on 26 January 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 26 January 2016 14:14:22 UTC

Original Document: http://www.aap.de/en/investors/news/2016/press-release-dated-january-26-2016